Publications by authors named "Rebekka Salgo"

Claim this Profile
E
Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data.
Greg A Knoll, Madzouka B Kokolo, Ranjeeta Mallick, Andrew Beck, Chieny D Buenaventura, Rebekka Salgo

BMJ· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-1β interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesis.
Claudia Buerger, Beatrice Richter, Kathrin Woth, Rebekka Salgo, Bartosz Malisiewicz

J Invest Dermatol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 41 year old man with an itchy rash.
Rebekka Salgo, Wolf-Henning Boehncke

BMJ· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial.
Sandra Boehncke, Stephan Fichtlscherer, Rebekka Salgo, Jurate Garbaraviciene, Heike Beschmann

Arch Dermatol Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in the sex hormone profile of male patients with moderate-to-severe plaque-type psoriasis under systemic therapy: results of a prospective longitudinal pilot study.
Sandra Boehncke, Rebekka Salgo, Jurate Garbaraviciene, Heike Beschmann, Hanns Ackermann

Arch Dermatol Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microdialysis documents changes in the micromilieu of psoriatic plaques under continuous systemic therapy.
Rebekka Salgo, Diamant Thaçi, Sandra Boehncke, Sandra Diehl, Matthias Hofmann

Exp Dermatol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies.
Diamant Thaçi, Rebekka Salgo

Clin Dermatol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The topical calcineurin inhibitor pimecrolimus in atopic dermatitis: a safety update.
Diamant Thaçi, Rebekka Salgo

Acta Dermatovenerol Alp Pannonica Adriat· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis